PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 192 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 1.40 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $502,000 | -8.6% | 5,651 | -8.7% | 0.01% | -6.7% |
| Q4 2014 | $549,000 | -17.6% | 6,192 | -9.8% | 0.02% | -21.1% |
| Q3 2014 | $666,000 | +4.6% | 6,867 | -1.0% | 0.02% | 0.0% |
| Q2 2014 | $637,000 | +31.3% | 6,934 | 0.0% | 0.02% | +26.7% |
| Q1 2014 | $485,000 | 0.0% | 6,934 | -17.8% | 0.02% | 0.0% |
| Q4 2013 | $485,000 | +12.0% | 8,440 | -6.4% | 0.02% | 0.0% |
| Q3 2013 | $433,000 | – | 9,017 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 273,000 | $8,818,000 | 6.24% |
| Standard Investments LLC | 775,388 | $25,045,000 | 4.58% |
| ARMISTICE CAPITAL, LLC | 400,000 | $12,920,000 | 3.06% |
| HealthCor Management, L.P. | 1,575,000 | $50,873,000 | 2.88% |
| DARUMA CAPITAL MANAGEMENT LLC | 1,219,642 | $39,394,000 | 2.24% |
| Consonance Capital Management LP | 631,805 | $20,407,000 | 2.24% |
| Rock Springs Capital Management LP | 713,000 | $23,030,000 | 1.54% |
| Biondo Investment Advisors, LLC | 142,473 | $4,602,000 | 1.52% |
| Opus Point Partners Management, LLC | 50,000 | $1,615,000 | 1.29% |
| Partner Investment Management, L.P. | 26,690 | $862,000 | 1.14% |